Related Articles
Evaluation of the optimal dosage of S-1 in adjuvant SOX chemotherapy for gastric cancer
Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer
First‑line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study
Phase I study of S-1 and biweekly docetaxel combination chemotherapy for advanced and recurrent gastric cancer
Phase I/II study of docetaxel, cisplatin and S‑1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma